ESTIMATING THE CONFIDENCE INTERVAL FOR THE COST-EFFECTIVENESS RATIO FROM A FAMILY OF REGRESSIONS ON NET MONETARY BENEFIT

被引：0

作者：

Gagnon, D. D. ^{[1
]}

机构：

[1] Thomson Reuters, Santa Barbara, CA USA

来源：

VALUE IN HEALTH | 2011年 / 14卷 / 07期

关键词：

D O I：

10.1016/j.jval.2011.08.1090

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：A431 / A431

页数：1

共 50 条

[1] The results of a pharmacoeconomic study: incremental cost-effectiveness ratio versus net monetary benefit
Messori, Andrea
Trippoli, Sabrina
[J]. HEART, 2017, 103 (21) : 1746 - 1746
[2] Incremental cost-effectiveness ratio and net monetary benefit: Current use in pharmacoeconomics and future perspectives
Trippoli, Sabrina
[J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 43 : E36 - E36
[3] Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?
O'Mahony, James F.
[J]. PHARMACOECONOMICS, 2020, 38 (08) : 777 - 779
[4] Does Cost-Effectiveness Analysis Really Need to Abandon the Incremental Cost-Effectiveness Ratio to Embrace Net Benefit?
James F. O’Mahony
[J]. PharmacoEconomics, 2020, 38 : 777 - 779
[5] The impact of statistical properties of incremental monetary net benefit and incremental cost-effectiveness ratio on health economic modeling choices
Yuan, Fei
Bangdiwala, Shrikant I.
Tong, Wesley
Lamy, Andre
[J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2023, 23 (01) : 69 - 78
[6] On parametric confidence intervals for the cost-effectiveness ratio
Gardiner, JC
Huebner, M
Jetton, J
Bradley, CJ
[J]. BIOMETRICAL JOURNAL, 2001, 43 (03) : 283 - 296
[7] IMPROVED BOOTSTRAP POINT AND CONFIDENCE INTERVAL ESTIMATION OF THE INCREMENTAL COST-EFFECTIVENESS RATIO (ICER)
Skrepnek, G. H.
Sahai, A.
[J]. VALUE IN HEALTH, 2014, 17 (03) : A201 - A201
[8] Bootstrapping: estimating confidence intervals for cost-effectiveness ratios
Campbell, MK
Torgerson, DJ
[J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 1999, 92 (03) : 177 - 182
[9] Incremental Cost-Effectiveness Ratio and Net Monetary Benefit: Promoting the Application of Value-Based Pricing to Medical Devices—A European Perspective
Andrea Messori
Sabrina Trippoli
[J]. Therapeutic Innovation & Regulatory Science, 2018, 52 : 755 - 756
[10] Incremental Net Benefit and Incremental Cost-Effectiveness Ratio of COVID-19 Vaccination Campaigns: Systematic Review of Cost-Effectiveness Evidence
Santoli, Giuseppe
Nurchis, Mario Cesare
Calabro, Giovanna Elisa
Damiani, Gianfranco
[J]. VACCINES, 2023, 11 (02)

← 1 2 3 4 5 →